An Effective Immuno-PET Imaging Method to Monitor CD8-Dependent Responses to Immunotherapy.
about
High-content molecular profiling of T-cell therapy in oncologyAdvances in Molecular Imaging Strategies for In Vivo Tracking of Immune CellsNuclear Molecular Imaging Strategies in Immune Checkpoint Inhibitor Therapy.Molecular Imaging of Immunotherapy Targets in Cancer.Quantitative CD3 PET Imaging Predicts Tumor Growth Response to Anti-CTLA-4 Therapy.Monitoring immune-checkpoint blockade: response evaluation and biomarker development.ImmunoPET Imaging of Murine CD4+ T Cells Using Anti-CD4 Cys-Diabody: Effects of Protein Dose on T Cell Function and Imaging.Emerging site-specific bioconjugation strategies for radioimmunotracer development.Advancing Immune and Cell-Based Therapies Through Imaging.The Advantages and Challenges of Using FDG PET/CT for Response Assessment in Melanoma in the Era of Targeted Agents and Immunotherapy.Implementing liquid biopsies into clinical decision making for cancer immunotherapy.The immune contexture in cancer prognosis and treatment.Immune Modulation Therapy and Imaging: Workshop Report.Noninvasive Imaging of Human Immune Responses in a Human Xenograft Model of Graft-Versus-Host Disease.Noninvasive monitoring of cancer therapy induced activated T cells using [18F]FB-IL-2 PET imaging.In-depth Characterization of a TCR-specific Tracer for Sensitive Detection of Tumor-directed Transgenic T Cells by Immuno-PETThe Challenge for Development of Valuable Immuno-oncology Biomarkers.Nano-enabled pancreas cancer immunotherapy using immunogenic cell death and reversing immunosuppression.Informatics for cancer immunotherapy.Tumor-associated macrophages, nanomedicine and imaging: the axis of success in the future of cancer immunotherapy.Predicting the response to CTLA-4 blockade by longitudinal noninvasive monitoring of CD8 T cells.Clinical characteristics of patient selection and imaging predictors of outcome in solid tumors treated with checkpoint-inhibitors.Murine Lymphocyte Labeling by 64Cu-Antibody Receptor Targeting for In Vivo Cell Trafficking by PET/CT.Cardiovascular Immunotherapy and the Role of Imaging.Correlation of metabolic information on FDG-PET with tissue expression of immune markers in patients with non-small cell lung cancer (NSCLC) who are candidates for upfront surgery.Aligning physics and physiology: Engineering antibodies for radionuclide delivery.Granzyme B PET Imaging as a Predictive Biomarker of Immunotherapy Response.Biomarkers for Clinical Benefit of Immune Checkpoint Inhibitor Treatment-A Review From the Melanoma Perspective and BeyondNon-invasive visualization of tumor infiltrating lymphocytes in patients with metastatic melanoma undergoing immune checkpoint inhibitor therapy: a pilot studyFluorine-19 MRI for detection and quantification of immune cell therapy for cancerEndogenous Galectin-1 in T Lymphocytes Regulates Anti-prostate Cancer ImmunityRole of noninvasive molecular imaging in determining response
P2860
Q28066792-D8376A41-C838-4381-877F-F188A9F0D133Q28076866-C983464B-E0E4-4B74-980B-83FF30C590DFQ33850467-89A88464-EF59-4B44-9195-EA5D515556D3Q37309882-FFF28BF1-3213-4798-B265-4B8F9C21F13DQ37722443-92FDE272-6242-406E-83CB-9CD70159C05BQ38666241-31836D58-5594-4C3F-A467-03C61BCDE472Q38783061-2D2B4E7B-8877-4080-86D0-47CCBD8DD8A8Q38818208-D6A2C540-EE28-4D60-A1E1-828379AD5CF5Q39167485-C6882093-7469-4C9F-95E0-CCF816B949D1Q39227781-A3331848-C022-4433-800A-1881584D31B6Q39304648-15A18C40-DE22-4B9A-B6F9-E26626131C3CQ39456999-8F829021-9E90-4518-90AE-1AF15909761BQ40089191-445CF313-7F97-4BED-84F2-95E0A06B5705Q40328875-8C2C07DB-C5F4-4FB8-BBBE-444D741E3072Q40336066-79F38D1E-400A-428C-8763-C115098A77B2Q41114267-8A7FCBD4-FA72-4688-9307-703E6AA94F9FQ46008297-DC554326-9F1A-4BDF-8DB4-14B8C1695757Q46014755-E9B0FBCD-6547-498F-97C0-17E02850FD2FQ47290509-EFB086F2-2E5E-4891-BA6C-EFFCA4BADED0Q47962563-D2474A5B-F570-48B7-97A2-405B0F3F2458Q48192595-059F990F-CCA7-429B-BE9B-89152206EC05Q48227716-B820AFB1-8A88-4FE3-BBF7-AB70F607B32CQ48554795-34074126-D204-4F7D-B6E5-ED0DF332E0D5Q50085133-7CE95848-07D9-48F2-9B61-D54D2446BC78Q50634571-0503D85C-5165-49B8-9F04-EFA666820BB3Q51740406-8A03765C-4570-430B-B4C7-5C0A57EB4022Q52874301-102AC450-EAC2-4479-9B5F-73EACEA44D3DQ56891609-A9C57064-3903-4F38-A701-BA195692F569Q57176193-777A06B4-9E68-4595-A2FF-310C5346E3A8Q57280956-F7A5A4C3-10DA-4AD2-946A-2BF0077D0962Q57491420-71B9DEF1-1F3E-46D4-B4CF-C399EDF7E9B8Q58119177-964EF566-F67E-4DC7-935B-0BA9398CA6CA
P2860
An Effective Immuno-PET Imaging Method to Monitor CD8-Dependent Responses to Immunotherapy.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
An Effective Immuno-PET Imagin ...... nt Responses to Immunotherapy.
@ast
An Effective Immuno-PET Imagin ...... nt Responses to Immunotherapy.
@en
type
label
An Effective Immuno-PET Imagin ...... nt Responses to Immunotherapy.
@ast
An Effective Immuno-PET Imagin ...... nt Responses to Immunotherapy.
@en
prefLabel
An Effective Immuno-PET Imagin ...... nt Responses to Immunotherapy.
@ast
An Effective Immuno-PET Imagin ...... nt Responses to Immunotherapy.
@en
P2093
P2860
P1433
P1476
An Effective Immuno-PET Imagin ...... nt Responses to Immunotherapy.
@en
P2093
Antoni Ribas
Felix B Salazar
Helena Escuin-Ordinas
Kirstin A Zettlitz
Melissa N McCracken
Owen N Witte
Richard Tavaré
Stephen Mok
P2860
P356
10.1158/0008-5472.CAN-15-1707
P407
P50
P577
2015-11-16T00:00:00Z